In this article
Hot flashes get most of the attention in menopause, but your bones are changing quietly too. Many women first hear the word osteoporosis after a bone density scan or a fracture, and wonder whether hormone therapy could have helped. This guide explains what estrogen does for bone, what the largest trials found, what HRT is and is not approved for, and what happens when you stop.
Why bone loss speeds up after menopause
Bone is living tissue. Throughout your life, your body breaks down old bone and builds new bone. Bone loss happens when more old bone is broken down than new bone is made [8]. A drop in estrogen at menopause is one of the causes of bone loss in women [8].
The Menopause Society explains that menopause increases bone breakdown, which doctors call resorption, and that estrogen therapy decreases it [1]. Osteoporosis is the result when bones become fragile and more likely to break [8]. Other risk factors include a family history of osteoporosis, low body weight, smoking, and heavy drinking [8].
Bone loss usually has no symptoms. The standard test is a DXA scan, a low-radiation x-ray of the hip and spine [7, 8]. MedlinePlus notes that the US Preventive Services Task Force recommends screening at least once for women 65 and older, and for some younger women at higher risk [8].
What the Women's Health Initiative found
The Women's Health Initiative (WHI) is the largest randomized trial of hormone therapy. Women were enrolled without regard to bone density or fracture risk, so most did not have osteoporosis [1]. That makes it a test of prevention.
Estrogen plus progestin
In the trial for women with a uterus, 16,608 women aged 50 to 79 took either a daily estrogen-plus-progestin pill or a placebo for an average of 5.6 years [2]. Fewer women on hormones had a fracture: 8.6% compared with 11.1% on placebo [2]. In a subgroup that had scans, total hip bone density rose 3.7% over three years on hormones, compared with 0.14% on placebo [2]. The fracture benefit was seen across every subgroup the researchers examined, including by age, weight, and fracture history [2].
- Fracture ~8.6%
- No fracture ~91.4%
- Fracture ~11.1%
- No fracture ~88.9%
In the WHI, 8.6% of women taking estrogen plus progestin had a fracture, compared with 11.1% of women on placebo [2].
Estrogen alone
In the trial for women who had a hysterectomy, 10,739 women took estrogen alone or a placebo for an average of about 7 years [3]. Estrogen alone lowered the risk of hip, spine, wrist, and total fractures, and modestly raised bone density [3]. The effect held regardless of age, whether the ovaries had been removed, or past fracture history [3]. Read more about this trial in HRT after hysterectomy.
In absolute numbers
The Menopause Society summarizes the WHI this way: in each trial, women on hormones had about six fewer hip fractures and six fewer spine fractures per 10,000 women compared with placebo [1]. A meta-analysis and systematic review, based mainly on the WHI, found that 5 to 7 years of hormone therapy significantly reduced spine, hip, and other fractures [1].
There is a nuance. In women who were 50 to 59 when they started, neither WHI trial showed a lower risk of hip fracture [1]. The Menopause Society says this may be partly because younger women without osteoporosis had a low risk of hip fracture to begin with [1].
Prevention, not treatment: what the FDA approves
This distinction trips up a lot of women. Hormone therapy is FDA-approved to prevent postmenopausal osteoporosis. It does not carry an FDA indication to treat osteoporosis, because randomized trials have not shown that it reduces fractures in women who already have osteoporosis [1]. The Menopause Society says non-estrogen medicines are preferred for treating existing osteoporosis [1].
Even for prevention, labels set limits. The Climara patch label says that when prescribing only to prevent osteoporosis, non-estrogen medicines should be considered first, and estrogen considered only for women at significant risk [5]. The estradiol tablet label says the same [6]. The NIH's National Institute of Arthritis and Musculoskeletal and Skin Diseases also notes that estrogen and hormone therapy are approved to prevent osteoporosis, and that women should weigh the risks and benefits carefully [7].
| Situation | What the sources say |
|---|---|
| Under 60 or within 10 years of menopause | Hormone therapy is an appropriate option to protect against bone loss, if there is no reason to avoid it [1] |
| Bone protection is the only goal | Consider non-estrogen medicines first; estrogen only for women at significant risk [5, 6] |
| Already diagnosed with osteoporosis | Not FDA-approved as treatment; non-estrogen medicines are preferred [1] |
| Premature menopause (before 40) | Hormone therapy or birth control pills are preferred over other bone drugs until the average age of menopause, if there is no prior fragility fracture or osteoporosis and no reason to avoid them [1] |
The Menopause Society adds that decisions about starting and stopping hormone therapy should be made mainly on the basis of benefits and risks beyond the bones, like relief of hot flashes [1]. In other words, bone protection is usually a welcome extra rather than the reason to start. For the full risk picture, see is HRT safe?
Doses used for bone
Some FDA-approved estradiol products list osteoporosis prevention among their uses. The Climara patch label starts at 0.025 mg per day for this purpose [5]. In a two-year trial on that label, 175 women who had a hysterectomy and did not have osteoporosis wore estradiol or placebo patches; bone density was preserved on every estradiol dose, while women on placebo lost bone [5]. For tablets, the label describes a study in which 0.5 mg a day for 23 days of each 28-day cycle prevented bone loss in the spine, and notes that the lowest effective dose for bone has not been determined [6].
The Menopause Society notes that hormone therapy's effect on bone density depends on dose [1]. Younger women with early menopause may need higher doses to protect bone [1]. Your clinician sets your dose; see our guide to estradiol dosage for how that works.
What happens to your bones when you stop
Estrogen's protection lasts only as long as you take it. The Menopause Society reports that within a few months of stopping, markers of bone turnover return to where they were before treatment, and bone density falls back to pre-treatment levels within one to two years [1]. The estradiol tablet label says bone mass declines after stopping at a rate similar to the years right after menopause [6].
That sounds alarming, but the fracture data are more reassuring. Researchers followed 15,187 WHI participants for five years after they stopped hormones or placebo [4]. Former hormone users did not have a higher fracture risk than former placebo users, either short-term or long-term [4]. Women who had taken estrogen alone even kept a small advantage for total fractures [4].
If you are planning to stop, talk with your clinician about your bone health first. They may suggest a bone density scan or another plan to protect your bones, especially if you have other risk factors.
Habits that matter with or without HRT
Medicine is only part of bone health. The NIH and the estradiol label both point to everyday steps [6, 7]:
- Strength or resistance training. Research suggests these are among the best activities for bone health. If you already have osteoporosis, avoid high-impact exercise [7].
- Weight-bearing activity, like walking [6].
- Calcium and vitamin D, from food or, if your intake falls short, supplements your clinician recommends [6, 7].
- Fall prevention, such as good lighting, rails on stairs, and supportive, nonslip shoes [7].
Hormone therapy at WarriorBabe Health
WarriorBabe Health treats menopause symptoms with options including an estradiol patch and an oral estradiol tablet, paired with a progesterone capsule for women who have a uterus. Your clinician reviews your history, including your bone health, before prescribing. If you already have osteoporosis, ask about treatments made for it, since non-estrogen medicines are preferred there [1]. Compare options on our hormone treatments page.
Our products are compounded by a licensed pharmacy. Compounded drugs are not FDA-approved, and the FDA does not review their safety, effectiveness, or quality before they are marketed [9]. The FDA osteoporosis-prevention indication described here belongs to specific FDA-approved products and does not extend to compounded hormones [9]. To see whether hormone therapy might suit your symptoms, take the 2-minute quiz.
Day to dayWhat to do day to day, from the WarriorBabe Show:Does strength training help bone density in menopause? →Frequently asked questions
Can HRT prevent osteoporosis?
Hormone therapy has been shown in randomized trials to prevent bone loss, and in the WHI it reduced fractures in women without osteoporosis [1]. Some estrogen products are FDA-approved for preventing postmenopausal osteoporosis [1, 5]. When bone protection is the only goal, labels say to consider non-estrogen medicines first [5, 6].
Is HRT a treatment for osteoporosis I already have?
No. Hormone therapy is not FDA-approved to treat osteoporosis, because trials have not shown it reduces fractures in women who already have it [1]. The Menopause Society says non-estrogen medicines are preferred for existing osteoporosis [1]. Talk with your clinician about treatment options.
What happens to my bones if I stop HRT?
Bone density tends to fall back to pre-treatment levels within one to two years of stopping [1]. However, in WHI women followed for five years after stopping, former hormone users did not have more fractures than former placebo users [4]. Talk with your clinician about a bone plan before you stop.
How much did HRT reduce fractures in the WHI?
In the estrogen-plus-progestin trial, 8.6% of women on hormones had a fracture, compared with 11.1% on placebo, over about 5.6 years [2]. Across both WHI trials, women on hormones had about six fewer hip fractures and six fewer spine fractures per 10,000 women [1].
Do I need a bone density scan before starting HRT?
Not necessarily, but it depends on your risk. The US Preventive Services Task Force recommends a DXA scan at least once for women 65 and older, and for some younger women at higher risk, according to MedlinePlus [8]. Ask your clinician whether a scan makes sense for you.
References
- The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. menopause.org/wp-content/uploads/professional/nams-2022-hormone-therapy-position-statement.pdf
- Cauley JA, Robbins J, Chen Z, et al. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA. 2003;290(13):1729-1738. pubmed.ncbi.nlm.nih.gov/14519707/
- Jackson RD, Wactawski-Wende J, LaCroix AZ, et al. Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: results from the Women's Health Initiative randomized trial. J Bone Miner Res. 2006;21(6):817-828. pubmed.ncbi.nlm.nih.gov/16753012/
- Watts NB, Cauley JA, Jackson RD, et al. No increase in fractures after stopping hormone therapy: results from the Women's Health Initiative. J Clin Endocrinol Metab. 2017;102(1):302-308. pubmed.ncbi.nlm.nih.gov/27820659/
- Bayer HealthCare Pharmaceuticals. Climara (estradiol transdermal system) prescribing information. DailyMed, US National Library of Medicine. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e9702c4-f2d7-4ea8-b6e8-7dca31671864
- Teva Pharmaceuticals USA. Estradiol tablets, USP, prescribing information. DailyMed, US National Library of Medicine. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c4936878-1643-4e7f-9b0d-e4957935aef2
- National Institute of Arthritis and Musculoskeletal and Skin Diseases. Osteoporosis: diagnosis, treatment, and steps to take. Reviewed 12/2022. www.niams.nih.gov/health-topics/osteoporosis/diagnosis-treatment-and-steps-to-take
- Osteoporosis. MedlinePlus Medical Encyclopedia. US National Library of Medicine. Reviewed 01/2025. medlineplus.gov/ency/article/000360.htm
- US Food and Drug Administration. Understanding the risks of compounded drugs. www.fda.gov/drugs/human-drug-compounding/understanding-risks-compounded-drugs
This article is for general information. It is not medical advice and does not replace a visit with a licensed clinician who knows your history. Do not start, stop or change a medication without talking to your clinician. If you think you are having a medical emergency, call 911.






